关注
Keita Hirai
Keita Hirai
School of Pharmaceutical Sciences, University of Shizuoka
在 u-shizuoka-ken.ac.jp 的电子邮件经过验证 - 首页
标题
引用次数
引用次数
年份
Antinociceptive effects of St. John's wort, Harpagophytum procumbens extract and Grape seed proanthocyanidins extract in mice
S Uchida, K Hirai, J Hatanaka, J Hanato, K Umegaki, S Yamada
Biological and Pharmaceutical Bulletin 31 (2), 240-245, 2008
992008
Augmented renal clearance in patients with febrile neutropenia is associated with increased risk for subtherapeutic concentrations of vancomycin
K Hirai, H Ishii, T Shimoshikiryo, T Shimomura, D Tsuji, K Inoue, T Kadoiri, ...
Therapeutic Drug Monitoring 38 (6), 706-710, 2016
772016
Combined assessment of serum periostin and YKL-40 may identify asthma-COPD overlap
T Shirai, K Hirai, Y Gon, S Maruoka, K Mizumura, M Hikichi, C Holweg, ...
The Journal of Allergy and Clinical Immunology: In Practice 7 (1), 134-145. e1, 2019
642019
Augmented renal clearance in pediatric patients with febrile neutropenia associated with vancomycin clearance.
K Hirai, S Ihara, A Kinae, K Ikegaya, M Suzuki, K Hirano, K Itoh
Therapeutic Drug Monitoring 38 (3), 393-397, 2016
622016
Simultaneous microdetermination of bosentan, ambrisentan, sildenafil, and tadalafil in plasma using liquid chromatography/tandem mass spectrometry for pediatric patients with …
Y Yokoyama, M Tomatsuri, H Hayashi, K Hirai, Y Ono, Y Yamada, ...
Journal of pharmaceutical and biomedical analysis 89, 227-232, 2014
462014
Role of type2 inflammatory biomarkers in chronic obstructive pulmonary disease
K Oishi, K Matsunaga, T Shirai, K Hirai, Y Gon
Journal of Clinical Medicine 9 (8), 2670, 2020
412020
The effect of CYP4F2, VKORC1 and CYP2C9 in influencing coumarin dose. A single patient data meta‐analysis in more than 15,000 individuals
E Danese, S Raimondi, M Montagnana, A Tagetti, T Langaee, P Borgiani, ...
Clinical Pharmacology & Therapeutics, 2018
412018
A clustering approach to identify and characterize the asthma and chronic obstructive pulmonary disease overlap phenotype
K Hirai, T Shirai, M Suzuki, T Akamatsu, T Suzuki, I Hayashi, A Yamamoto, ...
Clinical & Experimental Allergy 47 (11), 1374-1382, 2017
372017
Circulating microRNA‐15b‐5p as a biomarker for asthma‐COPD overlap
K Hirai, T Shirai, T Shimoshikiryo, M Ueda, Y Gon, S Maruoka, K Itoh
Allergy, 2020
322020
Drug-related genetic polymorphisms affecting severe chemotherapy-induced neutropenia in breast cancer patients: a hospital-based observational study
D Tsuji, M Ikeda, K Yamamoto, H Nakamori, YI Kim, Y Kawasaki, A Otake, ...
Medicine 95 (44), e5151, 2016
312016
Risk factors for hypernatremia in patients with short-and long-term tolvaptan treatment
K Hirai, T Shimomura, H Moriwaki, H Ishii, T Shimoshikiryo, D Tsuji, ...
European Journal of Clinical Pharmacology 72 (10), 1177–1183, 2016
312016
Influence of CYP4F2 polymorphisms and plasma vitamin K levels on warfarin sensitivity in Japanese pediatric patients
K Hirai, H Hayashi, Y Ono, K Izumiya, M Tanaka, T Suzuki, T Sakamoto, ...
Drug metabolism and pharmacokinetics 28 (2), 132-137, 2012
302012
Validation of a nomogram for achieving target trough concentration of vancomycin: accuracy in patients with augmented renal function
H Ishii, K Hirai, K Sugiyama, E Nakatani, M Kimura, K Itoh
Therapeutic Drug Monitoring 40 (6), 693-698, 2018
282018
Factors that influence the pharmacokinetics of lamotrigine in Japanese patients with epilepsy
K Inoue, Y Yamamoto, E Suzuki, T Takahashi, A Umemura, Y Takahashi, ...
European journal of clinical pharmacology 72 (5), 555-562, 2016
242016
Mucus plugs and small airway dysfunction in asthma, COPD, and asthma-COPD overlap
K Tamura, T Shirai, K Hirai, H Nakayasu, S Takahashi, Y Kishimoto, ...
Allergy, Asthma & Immunology Research 14 (2), 196, 2022
232022
Influence of ABCB1 and ABCG2 polymorphisms on the antiemetic efficacy in patients with cancer receiving cisplatin-based chemotherapy: a TRIPLE pharmacogenomics study
D Tsuji, M Yokoi, K Suzuki, T Daimon, M Nakao, H Ayuhara, Y Kogure, ...
The pharmacogenomics journal 17 (5), 435-440, 2017
232017
Plasma vitamin K concentrations depend on CYP4F2 polymorphism and influence on anticoagulation in Japanese patients with warfarin therapy
K Hirai, Y Yamada, H Hayashi, M Tanaka, K Izumiya, M Suzuki, ...
Thrombosis research 135 (5), 861-866, 2015
232015
Chemotherapy-induced neutropenia as a prognostic factor in patients with metastatic pancreatic cancer treated with gemcitabine
A Otake, D Tsuji, K Taku, Y Kawasaki, M Yokoi, H Nakamori, M Osada, ...
European Journal of Clinical Pharmacology 73, 1033-1039, 2017
192017
Association between (CCTTT)n repeat polymorphism in NOS2 promoter and asthma exacerbations
Keita Hirai, Toshihiro Shirai, Masayuki Suzuki, Tatsuki Shimomura, Kunihiko Itoh
Journal of Allergy and Clinical Immunology 142 (2), 663–665.e3, 2018
182018
Oscillometry improves earlier than spirometry after benralizumab initiation in severe asthma
T Shirai, T Akamatsu, K Hirai, H Watanabe, K Tamura, Y Kishimoto, ...
Allergy 75 (10), 2678-2680, 2020
172020
系统目前无法执行此操作,请稍后再试。
文章 1–20